Industry Briefs: July 30, 2012

A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

Coldstream Laboratories is expanding its Louisville, Kentucky, sterile-manufacturing facility. Read More

Dendreon has announced a restructuring plan to reduce costs by approximately $150 million annually. The plan includes the closure of its Morris Plains, New Jersey, manufacturing facility. Read More

GlaxoSmithKline has announced the acquisition of 79% of Human Genome Sciences’s shares, and is beginning a subsequent offering period to acquire the remaining shares. Read More

NSF International has acquired Becker & Associates Consulting, a clinical, regulatory, and scientific-consulting firm. Read More

People Notes

Array BioPharma has named Andrew Robbins as senior vice-president of commercial operations. Read More

Daicel has appointed Dieter Heckmann as executive officer. He will assume responsibility for global operations of the Chiral Pharmaceutical Ingredients company, reporting to Misao Fudaba, president and CEO of Daicel.

Quanticate has appointed Sally Du Toit as vice-president of pharmacovigilance and Chris Cramer as vice-president of clinical data management. Read More

Takeda Pharmaceutical has appointed Christopher Hohman as vice-president of its corporate communications department. Read More